US FDA authorises emergency use of Pfizer-BioNTech Covid-19 booster dose
The US Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) for a booster dose of Pfizer-BioNTech’s Covid-19 vaccine. The regulatory agency approved the booster dose